MAPT and Alzheimer disease: Given the selective binding of DMR7 and SKT82 to pathological tau, as well as inhibition of AD-tau seeded aggregation in primary neurons and hippocampal slice cultures, we evaluated whether these tau mAbs inhibit the transmission of tau pathology in vivo.